Predictable threats to public health through delaying universal access to innovative medicines for Hepatitis C: a pharmaceutical standpoint

Raffaella Ravinetto, Anja De Weggheleire, Thomas P C Dorlo, Sven Francque, An Sokkab, Corinne Pouget, Bruno Meessen, Patricia Tabernero, Paul N Newton, Lut Lynen

Research output: Contribution to journalA1: Web of Science-article

23 Downloads (Pure)

Fingerprint Dive into the research topics of 'Predictable threats to public health through delaying universal access to innovative medicines for Hepatitis C: a pharmaceutical standpoint'. Together they form a unique fingerprint.

Medicine & Life Sciences